Parsippany, NJ, United States of America

Viyyoor M Ginjavallabhan

This inventor holds 1 USPTO granted patent. Top assignee: Schering Corporation. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Viyyoor M Ginjavallabhan. Retrieved from https://idiyas.com/inventor/viyyoor-m-ginjavallabhan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Viyyoor M Ginjavallabhan: Innovator in Anti-Fungal Agents**

Introduction

Viyyoor M Ginjavallabhan is an accomplished inventor based in Parsippany, NJ, known for his significant contribution to the field of pharmaceuticals. With a focus on developing solutions for fungal infections, Ginjavallabhan has garnered recognition for his innovative approach to medicinal compounds.

Latest Patents

Viyyoor M Ginjavallabhan holds a notable patent related to anti-fungal agents. His patent describes compounds of a specific formula, which may include pharmaceutically acceptable salts. These compounds have been identified as useful agents in treating fungal infections, marking a significant advancement in pharmaceutical treatments.

Career Highlights

Ginjavallabhan has established his career at Schering Corporation, a prominent player in the pharmaceutical industry. His work has led to advancements in the development of anti-fungal treatments, showcasing his dedication to improving healthcare outcomes.

Collaborations

Throughout his career, Ginjavallabhan has collaborated with esteemed colleagues, including Alan B Cooper and Anil K Saksena. These partnerships have further enhanced the research and development efforts within the pharmaceutical sector, fostering innovation and creativity.

Conclusion

Viyyoor M Ginjavallabhan's contributions to the field of anti-fungal agents highlight the importance of innovation in medicine. His patent serves as a testament to his dedication and expertise, promising potential benefits for those suffering from fungal infections. As he continues to work at Schering Corporation, the impact of his innovations is sure to resonate in the pharmaceutical industry for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…